Our work also unveiled two clinically tested drugs that rescue AMD phenotypes in both CFH(H/H) and CFH(Y/Y) alleles, making them strong candidates with the potential to work on diverse AMD genotypes. Here, CFH is linked to age-related macular degeneration.